New Risk • Feb 22
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (€5.31m market cap, or US$6.26m). 공시 • Nov 21
Autins Group plc Announces Board Changes, Effective 19 November 2025 Autins Group plc announced the appointment of Trevor Brown as a Non-Executive Director of the Company, and resignation of Dr Qu Li as Non-Executive Director, with 19 November 2025. Trevor Brown is a director and representative of Truetide PLC ("Truetide"), previously Braveheart Investment Group PLC, which holds 29.09% of the Company's issued share capital. In conjunction with Trevor Brown's appointment, Dr Qu Li (also a director and representative of Truetide) will be stepping down as Non-Executive Director of the Company. The Company, Truetide and the Company's nominated adviser have a Relationship Agreement in place to ensure the Company is capable of carrying on its business independently at all times. Trevor Brown is currently Chief Executive Officer of Truetide PLC, trading on AIM, having joined the company as a non-executive director in 2014. Trevor has acted as a Chief Executive Officer, executive director and non-executive director for a wide range of both listed and private companies in a range of sectors over 40 years. Trevor is also Chief Executive Officer of Imaging Biometrics Limited, which is listed on the Main Market of the London Stock Exchange. In accordance with Schedule 2(g) of the AIM Rules for Companies, Trevor Edward Brown (aged 79) is, or has been within the previous five years, a director or partner of the following companies or partnerships: Current directorships/partnerships: Braveheart Academic Seed Funding GP Ltd, Chamberlin plc, Free Publishing Ltd, Imaging Biometrics Ltd, Kirkstall Ltd, Paraytec Ltd, Ridings Holdings Ltd, Stone Checker Software Ltd, Truetide Ltd. (formerly Braveheart Investment Group Ltd), Truetide PLC (formerly Braveheart Investment Group PLC), and The Ridings Early Growth Investment Company Ltd. Past directorships/partnerships: Combrook Holding Ltd, Free Association Books Ltd, and Nanosynth Group Plc. Reported Earnings • Oct 06
Full year 2025 earnings released: UK£0.02 loss per share (vs UK£0.009 loss in FY 2024) Full year 2025 results: UK£0.02 loss per share (further deteriorated from UK£0.009 loss in FY 2024). Revenue: UK£20.7m (down 12% from FY 2024). Net loss: UK£1.11m (loss widened 136% from FY 2024). Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 5.4% decline forecast for the Auto Components industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. New Risk • Jun 25
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 1.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (1.0% average weekly change). Market cap is less than US$10m (€6.40m market cap, or US$7.44m). Buy Or Sell Opportunity • Jun 25
Now 34% overvalued after recent price rise Over the last 90 days, the stock has risen 47% to €0.098. The fair value is estimated to be €0.073, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 54%. Reported Earnings • Jun 25
Full year 2025 earnings released: UK£0.02 loss per share (vs UK£0.009 loss in FY 2024) Full year 2025 results: UK£0.02 loss per share (further deteriorated from UK£0.009 loss in FY 2024). Revenue: UK£20.7m (down 12% from FY 2024). Net loss: UK£1.11m (loss widened 136% from FY 2024). Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 2.9% growth forecast for the Auto Components industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. 
